BHVN's Business Model
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Sector & Industry | Healthcare / Biotechnology |
Website | https://www.biohaven.com |
CEO (Chief Executive Officer) | Vladimir Coric |
Number of Employees | |
IPO date | September 23, 2022 |
BHVN Latest News
|
|
|
|
|
Contact | |
---|---|
Country | US |
Address | 215 Church Street |
City | New Haven |
State | CT |
Phone | 203 404 0410 |
Zip Code | 06510 |
Other Identifiers | |
CIK | 0001935979 |
ISIN | VGG1110E1079 |
CUSIP | G11196105 |
Open | 13.9 |
Previous Close | 13.79 |
Volume | 1.05 Mil. |
Average Volume | 2.17 Mil. |
Day’s Range | 13.85 – 14.18 |
52 Week Range | 13.745-55.7 |
MA (50) | 16.8028 |
MA (200) | 33.4526 |
Market Cap | 1.42 Bil. |
Shares Out. | 102.1 Mil. |
Earnings Date | Aug 05, 2025 |
Beta | |
Last Dividend | |
EPS | |
PE | |